Part 1 of this 3-part series for Global Biosimilars Week focuses on legal barriers to biosimilar access in the US, including the patent system, and discusses ongoing legislative efforts to address ...

The current US Supreme Court has no fundamental understanding of a range of medical, engineering, technological, or ...

Huonslab, a subsidiary of Huons Global and a major player in recombinant human hyaluronidase-based biologics Sub-Q delivery, announced on Nov. 11 that it has completed patent filing and examination ...

Patent examiners can make mistakes. Patent office clerks can misfile paperwork and cause procedural errors. The software tools, document formats like DOCX, and the IT systems your application passes ...

Ken D. Kumayama and Pramode Chiruvolu of Skadden, Arps, Slate, Meagher & Flom LLP discuss intellectual property protections ...

Encouraged and abetted by free riders who would benefit unfairly from others’ work, well-intentioned lawmakers and judicial ...

The US Patent and Trademark Office (USPTO ... USPTO DIRECTOR MAINTAINS SIGNIFICANT FLEXIBILITY IN DIRECTOR REVIEW PROCEDURES Consistent with the interim process, the Director retains significant ...

The U.S. built its thriving tech sector thanks to an effective patent system that rewards bright ideas. Colorado innovators ...

And second, with the Supreme Court's decision in September to deny serve, the legal process with respect to the 3 patents ...

Blockchain firm HUMBL recently announced that the United States Patent and Trademark ... long years spent getting this patent issued … [the length of the process] makes it hard for an early ...

What started off as a dice roll of a new practice group at Russ August & Kabat has turned into the breadwinner of the ...